CIK: 1770823 - Address: C/O Quince Therapeutics, Inc., 611 Gateway Blvd, Suite 273, South San Francisco, CA 94080
7 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/9/23 18:18
8/8/23
QNCXQuince Therapeutics, Inc.CAHealthBioPrdBiological Products, (No DiagMcLoughlin MargaretCADP101.2308New8D
10/12/21 17:48
10/8/21
CRTXCortexyme, Inc.DEHealthBioPrdBiological Products, (No DiagMcLoughlin MargaretCADM.d1717.00010D
10/12/21 17:48
10/8/21
CRTXCortexyme, Inc.DEHealthBioPrdBiological Products, (No DiagMcLoughlin MargaretCADS.d-8988.930-1-1000D
8/18/21 17:30
8/16/21
CRTXCortexyme, Inc.DEHealthBioPrdBiological Products, (No DiagMcLoughlin MargaretCADM.d10217.00060D
8/18/21 17:30
8/16/21
CRTXCortexyme, Inc.DEHealthBioPrdBiological Products, (No DiagMcLoughlin MargaretCADS.d-57395.440-6-1000D
6/29/21 17:26
6/28/21
CRTXCortexyme, Inc.DEHealthBioPrdBiological Products, (No DiagMcLoughlin MargaretCADS-3055.150-1-1000D
3/12/20 16:40
5/13/19
CRTXCortexyme, Inc.DEHealthBioPrdBiological Products, (No DiagMcLoughlin MargaretCADP917.0001New1D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact